Trials / Completed
CompletedNCT02371070
Point-of-Care Testing of Coagulation in Patients Treated With Direct Oral Anticoagulants 2
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 60 (actual)
- Sponsor
- University Hospital Tuebingen · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The investigators study aims to test the correlation between the Hemochron Signature point-of-care testing (POCT) device (ITC, USA) and low plasma levels of all three currently approved direct oral anticoagulants (DOAC; rivaroxaban, apixaban and dabigatran) and to determine the diagnostic accuracy of POCT to rule out or detect relevant levels of DOAC in real-life stroke patients.
Conditions
Timeline
- Start date
- 2013-12-01
- Primary completion
- 2015-11-01
- Completion
- 2016-05-01
- First posted
- 2015-02-25
- Last updated
- 2016-07-01
Source: ClinicalTrials.gov record NCT02371070. Inclusion in this directory is not an endorsement.